In this report, we present a rare case of a 17-year-old male patient with metastatic mesenchymal chondrosarcoma (MCS) managed with nonsurgical treatment who subsequently demonstrated a favorable response to concurrent chemotherapy and radiation therapy, followed with pazopanib target therapy. Further study regarding nonoperative care for metastatic MCS of spine is warranted.
Keywords: chemotherapy; mesenchymal chondrosarcoma; metastatic disease; radiation; spine; surgical resection.
© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.